{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:46:43Z","timestamp":1793407603432,"version":"4.5.0"},"reference-count":140,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,3,8]],"date-time":"2013-03-08T00:00:00Z","timestamp":1362700800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neuroimmune Pharmacol"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1007\/s11481-013-9445-9","type":"journal-article","created":{"date-parts":[[2013,3,7]],"date-time":"2013-03-07T06:12:48Z","timestamp":1362636768000},"page":"608-620","source":"Crossref","is-referenced-by-count":207,"title":["Cannabinoid Receptor 2: Potential Role in Immunomodulation and Neuroinflammation"],"prefix":"10.1007","volume":"8","author":[{"given":"Slava","family":"Rom","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuri","family":"Persidsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,3,8]]},"reference":[{"key":"9445_CR1","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1212\/01.wnl.0000253187.66183.9c","volume":"68","author":"DI Abrams","year":"2007","unstructured":"Abrams DI, Jay CA, Shade SB, Vizoso H, Reda H, Press S, Kelly ME, Rowbotham MC, Petersen KL (2007) Cannabis in painful HIV-associated sensory neuropathy: a randomized placebo-controlled trial. Neurology 68:515\u2013521","journal-title":"Neurology"},{"key":"9445_CR2","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1182\/blood-2012-06-435362","volume":"120","author":"S Adhikary","year":"2012","unstructured":"Adhikary S, Kocieda VP, Yen JH, Tuma RF, Ganea D (2012) Signaling through cannabinoid receptor 2 suppresses murine dendritic cell migration by inhibiting matrix metalloproteinase 9 expression. Blood 120:3741\u20133749","journal-title":"Blood"},{"key":"9445_CR3","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/bip.21179","volume":"91","author":"KH Ahn","year":"2009","unstructured":"Ahn KH, Pellegrini M, Tsomaia N, Yatawara AK, Kendall DA, Mierke DF (2009) Structural analysis of the human cannabinoid receptor one carboxyl-terminus identifies two amphipathic helices. Biopolymers 91:565\u2013573","journal-title":"Biopolymers"},{"key":"9445_CR4","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.phrs.2005.07.005","volume":"52","author":"JK Anday","year":"2005","unstructured":"Anday JK, Mercier RW (2005) Gene ancestry of the cannabinoid receptor family. Pharmacol Res 52:463\u2013466","journal-title":"Pharmacol Res"},{"key":"9445_CR5","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1600-0447.2011.01687.x","volume":"124","author":"CH Ashton","year":"2011","unstructured":"Ashton CH, Moore PB (2011) Endocannabinoid system dysfunction in mood and related disorders. Acta Psychiatr Scand 124:250\u2013261","journal-title":"Acta Psychiatr Scand"},{"key":"9445_CR6","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.neulet.2006.10.053","volume":"412","author":"JC Ashton","year":"2007","unstructured":"Ashton JC, Rahman RM, Nair SM, Sutherland BA, Glass M, Appleton I (2007) Cerebral hypoxia-ischemia and middle cerebral artery occlusion induce expression of the cannabinoid CB2 receptor in the brain. Neurosci Lett 412:114\u2013117","journal-title":"Neurosci Lett"},{"key":"9445_CR7","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.pnpbp.2011.12.001","volume":"38","author":"BK Atwood","year":"2012","unstructured":"Atwood BK, Straiker A, Mackie K (2012) CB(2): therapeutic target-in-waiting. Prog Neuropsychopharmacol Biol Psychiatry 38:16\u201320","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"9445_CR8","first-page":"114","volume":"261","author":"JL Azorlosa","year":"1992","unstructured":"Azorlosa JL, Heishman SJ, Stitzer ML, Mahaffey JM (1992) Marijuana smoking: effect of varying delta 9-tetrahydrocannabinol content and number of puffs. J Pharmacol Exp Ther 261:114\u2013122","journal-title":"J Pharmacol Exp Ther"},{"key":"9445_CR9","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1096\/fj.00-0399fje","volume":"15","author":"D Baker","year":"2001","unstructured":"Baker D, Pryce G, Croxford JL, Brown P, Pertwee RG, Makriyannis A, Khanolkar A, Layward L, Fezza F, Bisogno T, Di Marzo V (2001) Endocannabinoids control spasticity in a multiple sclerosis model. FASEB J 15:300\u2013302","journal-title":"FASEB J"},{"key":"9445_CR10","unstructured":"Barbato L (2007) Dronabinol treatment for migraine. In. US"},{"key":"9445_CR11","doi-asserted-by":"crossref","first-page":"4971","DOI":"10.4049\/jimmunol.177.8.4971","volume":"177","author":"M Bari","year":"2006","unstructured":"Bari M, Spagnuolo P, Fezza F, Oddi S, Pasquariello N, Finazzi-Agro A, Maccarrone M (2006) Effect of lipid rafts on Cb2 receptor signaling and 2-arachidonoyl-glycerol metabolism in human immune cells. J Immunol 177:4971\u20134980","journal-title":"J Immunol"},{"key":"9445_CR12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jep.2006.02.001","volume":"105","author":"M Ben Amar","year":"2006","unstructured":"Ben Amar M (2006) Cannabinoids in medicine: a review of their therapeutic potential. J Ethnopharmacol 105:1\u201325","journal-title":"J Ethnopharmacol"},{"key":"9445_CR13","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/sj.bjp.0707505","volume":"153","author":"C Benito","year":"2008","unstructured":"Benito C, Tolon RM, Pazos MR, Nunez E, Castillo AI, Romero J (2008) Cannabinoid CB2 receptors in human brain inflammation. Br J Pharmacol 153:277\u2013285","journal-title":"Br J Pharmacol"},{"key":"9445_CR14","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1523\/JNEUROSCI.3923-04.2005","volume":"25","author":"C Benito","year":"2005","unstructured":"Benito C, Kim WK, Chavarria I, Hillard CJ, Mackie K, Tolon RM, Williams K, Romero J (2005) A glial endogenous cannabinoid system is upregulated in the brains of macaques with simian immunodeficiency virus-induced encephalitis. J Neurosci 25:2530\u20132536","journal-title":"J Neurosci"},{"key":"9445_CR15","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1523\/JNEUROSCI.4814-06.2007","volume":"27","author":"C Benito","year":"2007","unstructured":"Benito C, Romero JP, Tolon RM, Clemente D, Docagne F, Hillard CJ, Guaza C, Romero J (2007) Cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis. J Neurosci 27:2396\u20132402","journal-title":"J Neurosci"},{"key":"9445_CR16","doi-asserted-by":"crossref","first-page":"PL125","DOI":"10.1016\/S0024-3205(98)00324-5","volume":"63","author":"E Berdyshev","year":"1998","unstructured":"Berdyshev E, Boichot E, Corbel M, Germain N, Lagente V (1998) Effects of cannabinoid receptor ligands on LPS-induced pulmonary inflammation in mice. Life Sci 63:PL125\u2013PL129","journal-title":"Life Sci"},{"key":"9445_CR17","first-page":"506","volume":"26","author":"M Carissimi","year":"1976","unstructured":"Carissimi M, Gentili P, Grumelli E, Milla E, Picciola G, Ravenna F (1976) Basic ethers of cyclohexylphenols with beta-blocking activity: synthesis and pharmacological study of exaprolol. Arzneimittelforschung 26:506\u2013516","journal-title":"Arzneimittelforschung"},{"key":"9445_CR18","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S1567-5769(01)00147-3","volume":"2","author":"SJ Carlisle","year":"2002","unstructured":"Carlisle SJ, Marciano-Cabral F, Staab A, Ludwick C, Cabral GA (2002) Differential expression of the CB2 cannabinoid receptor by rodent macrophages and macrophage-like cells in relation to cell activation. Int Immunopharmacol 2:69\u201382","journal-title":"Int Immunopharmacol"},{"key":"9445_CR19","first-page":"807","volume":"293","author":"Y Chen","year":"2000","unstructured":"Chen Y, Buck J (2000) Cannabinoids protect cells from oxidative cell death: a receptor-independent mechanism. J Pharmacol Exp Ther 293:807\u2013812","journal-title":"J Pharmacol Exp Ther"},{"key":"9445_CR20","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.intimp.2003.12.011","volume":"4","author":"S Chuchawankul","year":"2004","unstructured":"Chuchawankul S, Shima M, Buckley NE, Hartmann CB, McCoy KL (2004) Role of cannabinoid receptors in inhibiting macrophage costimulatory activity. Int Immunopharmacol 4:265\u2013278","journal-title":"Int Immunopharmacol"},{"key":"9445_CR21","doi-asserted-by":"crossref","first-page":"13175","DOI":"10.1074\/jbc.271.22.13175","volume":"271","author":"R Condie","year":"1996","unstructured":"Condie R, Herring A, Koh WS, Lee M, Kaminski NE (1996) Cannabinoid inhibition of adenylate cyclase-mediated signal transduction and interleukin 2 (IL-2) expression in the murine T-cell line, EL4.IL-2. J Biol Chem 271:13175\u201313183","journal-title":"J Biol Chem"},{"key":"9445_CR22","doi-asserted-by":"crossref","unstructured":"Console-Bram L, Marcu J, Abood ME (2012) Cannabinoid receptors: nomenclature and pharmacological principles. Prog Neuropsychopharmacol Biol Psychiatry","DOI":"10.1016\/j.pnpbp.2012.02.009"},{"key":"9445_CR23","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/sj.bjp.0704466","volume":"135","author":"S Conti","year":"2002","unstructured":"Conti S, Costa B, Colleoni M, Parolaro D, Giagnoni G (2002) Antiinflammatory action of endocannabinoid palmitoylethanolamide and the synthetic cannabinoid nabilone in a model of acute inflammation in the rat. Br J Pharmacol 135:181\u2013187","journal-title":"Br J Pharmacol"},{"key":"9445_CR24","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.bcp.2008.09.014","volume":"77","author":"F Correa","year":"2009","unstructured":"Correa F, Docagne F, Mestre L, Clemente D, Hernangomez M, Loria F, Guaza C (2009) A role for CB2 receptors in anandamide signalling pathways involved in the regulation of IL-12 and IL-23 in microglial cells. Biochem Pharmacol 77:86\u2013100","journal-title":"Biochem Pharmacol"},{"key":"9445_CR25","doi-asserted-by":"crossref","first-page":"e33961","DOI":"10.1371\/journal.pone.0033961","volume":"7","author":"CM Costantino","year":"2012","unstructured":"Costantino CM, Gupta A, Yewdall AW, Dale BM, Devi LA, Chen BK (2012) Cannabinoid receptor 2-mediated attenuation of CXCR4-tropic HIV infection in primary CD4+ T cells. PLoS One 7:e33961","journal-title":"PLoS One"},{"key":"9445_CR26","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000099240","volume":"39","author":"J Crandall","year":"2007","unstructured":"Crandall J, Matragoon S, Khalifa YM, Borlongan C, Tsai NT, Caldwell RB, Liou GI (2007) Neuroprotective and intraocular pressure-lowering effects of (\u2212)Delta9-tetrahydrocannabinol in a rat model of glaucoma. Ophthalmic Res 39:69\u201375","journal-title":"Ophthalmic Res"},{"key":"9445_CR27","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1017\/S1461145705006206","volume":"9","author":"JA Crippa","year":"2006","unstructured":"Crippa JA, Zuardi AW (2006) Duloxetine in the treatment of panic disorder. Int J Neuropsychopharmacol 9:633\u2013634","journal-title":"Int J Neuropsychopharmacol"},{"key":"9445_CR28","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1007\/s00018-008-8139-6","volume":"65","author":"E Dainese","year":"2008","unstructured":"Dainese E, Oddi S, Maccarrone M (2008) Lipid-mediated dimerization of beta2-adrenergic receptor reveals important clues for cannabinoid receptors. Cell Mol Life Sci 65:2277\u20132279","journal-title":"Cell Mol Life Sci"},{"key":"9445_CR29","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1177\/1545109707300157","volume":"6","author":"E Dejesus","year":"2007","unstructured":"Dejesus E, Rodwick BM, Bowers D, Cohen CJ, Pearce D (2007) Use of Dronabinol improves appetite and reverses weight loss in HIV\/AIDS-infected patients. J Int Assoc Physicians AIDS Care (Chic) 6:95\u2013100","journal-title":"J Int Assoc Physicians AIDS Care (Chic)"},{"key":"9445_CR30","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0014-5793(95)00746-V","volume":"369","author":"JM Derocq","year":"1995","unstructured":"Derocq JM, Segui M, Marchand J, Le Fur G, Casellas P (1995) Cannabinoids enhance human B-cell growth at low nanomolar concentrations. FEBS Lett 369:177\u2013182","journal-title":"FEBS Lett"},{"key":"9445_CR31","first-page":"605","volume":"34","author":"WA Devane","year":"1988","unstructured":"Devane WA, Dysarz FA 3rd, Johnson MR, Melvin LS, Howlett AC (1988) Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol 34:605\u2013613","journal-title":"Mol Pharmacol"},{"key":"9445_CR32","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.mcn.2006.12.005","volume":"34","author":"F Docagne","year":"2007","unstructured":"Docagne F, Muneton V, Clemente D, Ali C, Loria F, Correa F, Hernangomez M, Mestre L, Vivien D, Guaza C (2007) Excitotoxicity in a chronic model of multiple sclerosis: neuroprotective effects of cannabinoids through CB1 and CB2 receptor activation. Mol Cell Neurosci 34:551\u2013561","journal-title":"Mol Cell Neurosci"},{"key":"9445_CR33","first-page":"2190","volume":"14","author":"AB El-Remessy","year":"2008","unstructured":"El-Remessy AB, Tang Y, Zhu G, Matragoon S, Khalifa Y, Liu EK, Liu JY, Hanson E, Mian S, Fatteh N, Liou GI (2008) Neuroprotective effects of cannabidiol in endotoxin-induced uveitis: critical role of p38 MAPK activation. Mol Vis 14:2190\u20132203","journal-title":"Mol Vis"},{"key":"9445_CR34","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.neuron.2005.11.027","volume":"49","author":"E Eljaschewitsch","year":"2006","unstructured":"Eljaschewitsch E, Witting A, Mawrin C, Lee T, Schmidt PM, Wolf S, Hoertnagl H, Raine CS, Schneider-Stock R, Nitsch R, Ullrich O (2006) The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells. Neuron 49:67\u201379","journal-title":"Neuron"},{"key":"9445_CR35","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.it.2005.07.004","volume":"26","author":"B Engelhardt","year":"2005","unstructured":"Engelhardt B, Ransohoff RM (2005) The ins and outs of T-lymphocyte trafficking to the CNS: anatomical sites and molecular mechanisms. Trends Immunol 26:485\u2013495","journal-title":"Trends Immunol"},{"key":"9445_CR36","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/glia.10177","volume":"41","author":"F Facchinetti","year":"2003","unstructured":"Facchinetti F, Del Giudice E, Furegato S, Passarotto M, Leon A (2003) Cannabinoids ablate release of TNFalpha in rat microglial cells stimulated with lypopolysaccharide. Glia 41:161\u2013168","journal-title":"Glia"},{"key":"9445_CR37","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1152\/jn.1995.73.2.907","volume":"73","author":"P Fan","year":"1995","unstructured":"Fan P (1995) Cannabinoid agonists inhibit the activation of 5-HT3 receptors in rat nodose ganglion neurons. J Neurophysiol 73:907\u2013910","journal-title":"J Neurophysiol"},{"key":"9445_CR38","first-page":"443","volume":"48","author":"CC Felder","year":"1995","unstructured":"Felder CC, Joyce KE, Briley EM, Mansouri J, Mackie K, Blond O, Lai Y, Ma AL, Mitchell RL (1995) Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors. Mol Pharmacol 48:443\u2013450","journal-title":"Mol Pharmacol"},{"key":"9445_CR39","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1203\/01.pdr.0000228839.00122.6c","volume":"60","author":"D Fernandez-Lopez","year":"2006","unstructured":"Fernandez-Lopez D, Martinez-Orgado J, Nunez E, Romero J, Lorenzo P, Moro MA, Lizasoain I (2006) Characterization of the neuroprotective effect of the cannabinoid agonist WIN-55212 in an in vitro model of hypoxic-ischemic brain damage in newborn rats. Pediatr Res 60:169\u2013173","journal-title":"Pediatr Res"},{"key":"9445_CR40","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/s11481-011-9291-6","volume":"6","author":"D Fraga","year":"2011","unstructured":"Fraga D, Raborn ES, Ferreira GA, Cabral GA (2011) Cannabinoids inhibit migration of microglial-like cells to the HIV protein Tat. J Neuroimmune Pharmacol 6:566\u2013577","journal-title":"J Neuroimmune Pharmacol"},{"key":"9445_CR41","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1021\/ja00730a036","volume":"93","author":"Y Gaoni","year":"1971","unstructured":"Gaoni Y, Mechoulam R (1971) The isolation and structure of delta-1-tetrahydrocannabinol and other neutral cannabinoids from hashish. J Am Chem Soc 93:217\u2013224","journal-title":"J Am Chem Soc"},{"key":"9445_CR42","doi-asserted-by":"crossref","first-page":"9099","DOI":"10.1073\/pnas.0803601105","volume":"105","author":"J Gertsch","year":"2008","unstructured":"Gertsch J, Leonti M, Raduner S, Racz I, Chen JZ, Xie XQ, Altmann KH, Karsak M, Zimmer A (2008) Beta-caryophyllene is a dietary cannabinoid. Proc Natl Acad Sci U S A 105:9099\u20139104","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9445_CR43","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.molbrainres.2004.08.025","volume":"132","author":"SA Golech","year":"2004","unstructured":"Golech SA, McCarron RM, Chen Y, Bembry J, Lenz F, Mechoulam R, Shohami E, Spatz M (2004) Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors. Brain Res Mol Brain Res 132:87\u201392","journal-title":"Brain Res Mol Brain Res"},{"key":"9445_CR44","doi-asserted-by":"crossref","first-page":"8268","DOI":"10.1073\/pnas.95.14.8268","volume":"95","author":"AJ Hampson","year":"1998","unstructured":"Hampson AJ, Grimaldi M, Axelrod J, Wink D (1998) Cannabidiol and (\u2212)Delta9-tetrahydrocannabinol are neuroprotective antioxidants. Proc Natl Acad Sci U S A 95:8268\u20138273","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9445_CR45","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1093\/cvr\/cvp240","volume":"84","author":"KH Han","year":"2009","unstructured":"Han KH, Lim S, Ryu J, Lee CW, Kim Y, Kang JH, Kang SS, Ahn YK, Park CS, Kim JJ (2009) CB1 and CB2 cannabinoid receptors differentially regulate the production of reactive oxygen species by macrophages. Cardiovasc Res 84:378\u2013386","journal-title":"Cardiovasc Res"},{"key":"9445_CR46","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0091-3057(89)90369-9","volume":"34","author":"SJ Heishman","year":"1989","unstructured":"Heishman SJ, Stitzer ML, Yingling JE (1989) Effects of tetrahydrocannabinol content on marijuana smoking behavior, subjective reports, and performance. Pharmacol Biochem Behav 34:173\u2013179","journal-title":"Pharmacol Biochem Behav"},{"key":"9445_CR47","doi-asserted-by":"crossref","unstructured":"Howlett AC (2005) Cannabinoid receptor signaling. Handb Exp Pharmacol pp 53\u201379","DOI":"10.1007\/3-540-26573-2_2"},{"key":"9445_CR48","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1124\/pr.54.2.161","volume":"54","author":"AC Howlett","year":"2002","unstructured":"Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, Devane WA, Felder CC, Herkenham M, Mackie K, Martin BR, Mechoulam R, Pertwee RG (2002) International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev 54:161\u2013202","journal-title":"Pharmacol Rev"},{"key":"9445_CR49","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1002\/cbdv.200790152","volume":"4","author":"MA Huestis","year":"2007","unstructured":"Huestis MA (2007) Human cannabinoid pharmacokinetics. Chem Biodivers 4:1770\u20131804","journal-title":"Chem Biodivers"},{"key":"9445_CR50","doi-asserted-by":"crossref","first-page":"5432","DOI":"10.1016\/j.bmcl.2006.07.051","volume":"16","author":"JW Huffman","year":"2006","unstructured":"Huffman JW, Padgett LW, Isherwood ML, Wiley JL, Martin BR (2006) 1-Alkyl-2-aryl-4-(1-naphthoyl)pyrroles: new high affinity ligands for the cannabinoid CB1 and CB2 receptors. Bioorg Med Chem Lett 16:5432\u20135435","journal-title":"Bioorg Med Chem Lett"},{"key":"9445_CR51","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0968-0896(99)00305-3","volume":"8","author":"JW Huffman","year":"2000","unstructured":"Huffman JW, Lu J, Dai D, Kitaygorodskiy A, Wiley JL, Martin BR (2000) Synthesis and pharmacology of a hybrid cannabinoid. Bioorg Med Chem 8:439\u2013447","journal-title":"Bioorg Med Chem"},{"key":"9445_CR52","doi-asserted-by":"crossref","first-page":"7809","DOI":"10.1016\/j.bmc.2010.09.061","volume":"18","author":"JW Huffman","year":"2010","unstructured":"Huffman JW, Hepburn SA, Lyutenko N, Thompson AL, Wiley JL, Selley DE, Martin BR (2010) 1-Bromo-3-(1\u2032,1\u2032-dimethylalkyl)-1-deoxy-Delta(8)-tetrahydrocannabinols: new selective ligands for the cannabinoid CB(2) receptor. Bioorg Med Chem 18:7809\u20137815","journal-title":"Bioorg Med Chem"},{"key":"9445_CR53","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1021\/jm960394y","volume":"39","author":"JW Huffman","year":"1996","unstructured":"Huffman JW, Yu S, Showalter V, Abood ME, Wiley JL, Compton DR, Martin BR, Bramblett RD, Reggio PH (1996) Synthesis and pharmacology of a very potent cannabinoid lacking a phenolic hydroxyl with high affinity for the CB2 receptor. J Med Chem 39:3875\u20133877","journal-title":"J Med Chem"},{"key":"9445_CR54","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0968-0896(02)00451-0","volume":"11","author":"JW Huffman","year":"2003","unstructured":"Huffman JW, Mabon R, Wu MJ, Lu J, Hart R, Hurst DP, Reggio PH, Wiley JL, Martin BR (2003) 3-Indolyl-1-naphthylmethanes: new cannabimimetic indoles provide evidence for aromatic stacking interactions with the CB(1) cannabinoid receptor. Bioorg Med Chem 11:539\u2013549","journal-title":"Bioorg Med Chem"},{"key":"9445_CR55","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.bmc.2004.09.050","volume":"13","author":"JW Huffman","year":"2005","unstructured":"Huffman JW, Zengin G, Wu MJ, Lu J, Hynd G, Bushell K, Thompson AL, Bushell S, Tartal C, Hurst DP, Reggio PH, Selley DE, Cassidy MP, Wiley JL, Martin BR (2005) Structure-activity relationships for 1-alkyl-3-(1-naphthoyl)indoles at the cannabinoid CB(1) and CB(2) receptors: steric and electronic effects of naphthoyl substituents. New highly selective CB(2) receptor agonists. Bioorg Med Chem 13:89\u2013112","journal-title":"Bioorg Med Chem"},{"key":"9445_CR56","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.2165\/11585260-000000000-00000","volume":"70","author":"M Karst","year":"2010","unstructured":"Karst M, Wippermann S, Ahrens J (2010) Role of cannabinoids in the treatment of pain and (painful) spasticity. Drugs 70:2409\u20132438","journal-title":"Drugs"},{"key":"9445_CR57","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1124\/mol.111.071647","volume":"80","author":"HJ Kim","year":"2011","unstructured":"Kim HJ, Shin AH, Thayer SA (2011) Activation of cannabinoid type 2 receptors inhibits HIV-1 envelope glycoprotein gp120-induced synapse loss. Mol Pharmacol 80:357\u2013366","journal-title":"Mol Pharmacol"},{"key":"9445_CR58","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ejphar.2006.05.025","volume":"542","author":"K Kim","year":"2006","unstructured":"Kim K, Moore DH, Makriyannis A, Abood ME (2006) AM1241, a cannabinoid CB2 receptor selective compound, delays disease progression in a mouse model of amyotrophic lateral sclerosis. Eur J Pharmacol 542:100\u2013105","journal-title":"Eur J Pharmacol"},{"key":"9445_CR59","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/sj.bjp.0705304","volume":"139","author":"A Klegeris","year":"2003","unstructured":"Klegeris A, Bissonnette CJ, McGeer PL (2003) Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptor. Br J Pharmacol 139:775\u2013786","journal-title":"Br J Pharmacol"},{"key":"9445_CR60","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1124\/jpet.107.120865","volume":"322","author":"NM Kogan","year":"2007","unstructured":"Kogan NM, Schlesinger M, Peters M, Marincheva G, Beeri R, Mechoulam R (2007) A cannabinoid anticancer quinone, HU-331, is more potent and less cardiotoxic than doxorubicin: a comparative in vivo study. J Pharmacol Exp Ther 322:646\u2013653","journal-title":"J Pharmacol Exp Ther"},{"key":"9445_CR61","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2174\/157488907780832733","volume":"2","author":"AV Krymchantowski","year":"2007","unstructured":"Krymchantowski AV, Jevoux Cda C (2007) The experience of combining agents, specially triptans and non steroidal anti-inflammatory drugs, for the acute treatment of migraine - a review. Recent Pat CNS Drug Discov 2:141\u2013144","journal-title":"Recent Pat CNS Drug Discov"},{"key":"9445_CR62","doi-asserted-by":"crossref","first-page":"12908","DOI":"10.1074\/jbc.M510871200","volume":"281","author":"R Kurihara","year":"2006","unstructured":"Kurihara R, Tohyama Y, Matsusaka S, Naruse H, Kinoshita E, Tsujioka T, Katsumata Y, Yamamura H (2006) Effects of peripheral cannabinoid receptor ligands on motility and polarization in neutrophil-like HL60 cells and human neutrophils. J Biol Chem 281:12908\u201312918","journal-title":"J Biol Chem"},{"key":"9445_CR63","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1471-2377-9-59","volume":"9","author":"SE Lakhan","year":"2009","unstructured":"Lakhan SE, Rowland M (2009) Whole plant cannabis extracts in the treatment of spasticity in multiple sclerosis: a systematic review. BMC Neurol 9:59","journal-title":"BMC Neurol"},{"key":"9445_CR64","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2042-7158.1984.tb04376.x","volume":"36","author":"B Law","year":"1984","unstructured":"Law B, Mason PA, Moffat AC, Gleadle RI, King LJ (1984) Forensic aspects of the metabolism and excretion of cannabinoids following oral ingestion of cannabis resin. J Pharm Pharmacol 36:289\u2013294","journal-title":"J Pharm Pharmacol"},{"key":"9445_CR65","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0014-2999(01)01122-0","volume":"423","author":"SF Lee","year":"2001","unstructured":"Lee SF, Newton C, Widen R, Friedman H, Klein TW (2001) Differential expression of cannabinoid CB(2) receptor mRNA in mouse immune cell subpopulations and following B cell stimulation. Eur J Pharmacol 423:235\u2013241","journal-title":"Eur J Pharmacol"},{"key":"9445_CR66","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1177\/1756285612453972","volume":"5","author":"VI Leussink","year":"2012","unstructured":"Leussink VI, Husseini L, Warnke C, Broussalis E, Hartung HP, Kieseier BC (2012) Symptomatic therapy in multiple sclerosis: the role of cannabinoids in treating spasticity. Ther Adv Neurol Disord 5:255\u2013266","journal-title":"Ther Adv Neurol Disord"},{"key":"9445_CR67","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1601-183X.2009.00498.x","volume":"8","author":"QR Liu","year":"2009","unstructured":"Liu QR, Pan CH, Hishimoto A, Li CY, Xi ZX, Llorente-Berzal A, Viveros MP, Ishiguro H, Arinami T, Onaivi ES, Uhl GR (2009) Species differences in cannabinoid receptor 2 (CNR2 gene): identification of novel human and rodent CB2 isoforms, differential tissue expression and regulation by cannabinoid receptor ligands. Genes Brain Behav 8:519\u2013530","journal-title":"Genes Brain Behav"},{"key":"9445_CR68","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.clim.2006.11.002","volume":"122","author":"C Lombard","year":"2007","unstructured":"Lombard C, Nagarkatti M, Nagarkatti P (2007) CB2 cannabinoid receptor agonist, JWH-015, triggers apoptosis in immune cells: potential role for CB2-selective ligands as immunosuppressive agents. Clin Immunol 122:259\u2013270","journal-title":"Clin Immunol"},{"key":"9445_CR69","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1002\/hep.24524","volume":"54","author":"A Louvet","year":"2011","unstructured":"Louvet A, Teixeira-Clerc F, Chobert MN, Deveaux V, Pavoine C, Zimmer A, Pecker F, Mallat A, Lotersztajn S (2011) Cannabinoid CB2 receptors protect against alcoholic liver disease by regulating Kupffer cell polarization in mice. Hepatology 54:1217\u20131226","journal-title":"Hepatology"},{"key":"9445_CR70","doi-asserted-by":"crossref","first-page":"6406","DOI":"10.4049\/jimmunol.181.9.6406","volume":"181","author":"TS Lu","year":"2008","unstructured":"Lu TS, Avraham HK, Seng S, Tachado SD, Koziel H, Makriyannis A, Avraham S (2008) Cannabinoids inhibit HIV-1 Gp120-mediated insults in brain microvascular endothelial cells. J Immunol 181:6406\u20136416","journal-title":"J Immunol"},{"key":"9445_CR71","doi-asserted-by":"crossref","first-page":"3778","DOI":"10.1021\/jm0001572","volume":"43","author":"A Mahadevan","year":"2000","unstructured":"Mahadevan A, Siegel C, Martin BR, Abood ME, Beletskaya I, Razdan RK (2000) Novel cannabinol probes for CB1 and CB2 cannabinoid receptors. J Med Chem 43:3778\u20133785","journal-title":"J Med Chem"},{"key":"9445_CR72","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/nm1561","volume":"13","author":"K Maresz","year":"2007","unstructured":"Maresz K, Pryce G, Ponomarev ED, Marsicano G, Croxford JL, Shriver LP, Ledent C, Cheng X, Carrier EJ, Mann MK, Giovannoni G, Pertwee RG, Yamamura T, Buckley NE, Hillard CJ, Lutz B, Baker D, Dittel BN (2007) Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells. Nat Med 13:492\u2013497","journal-title":"Nat Med"},{"key":"9445_CR73","doi-asserted-by":"crossref","first-page":"4213","DOI":"10.1046\/j.1460-9568.1999.00847.x","volume":"11","author":"G Marsicano","year":"1999","unstructured":"Marsicano G, Lutz B (1999) Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain. Eur J Neurosci 11:4213\u20134225","journal-title":"Eur J Neurosci"},{"key":"9445_CR74","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.1088208","volume":"302","author":"G Marsicano","year":"2003","unstructured":"Marsicano G, Goodenough S, Monory K, Hermann H, Eder M, Cannich A, Azad SC, Cascio MG, Gutierrez SO, van der Stelt M, Lopez-Rodriguez ML, Casanova E, Schutz G, Zieglgansberger W, Di Marzo V, Behl C, Lutz B (2003) CB1 cannabinoid receptors and on-demand defense against excitotoxicity. Science 302:84\u201388","journal-title":"Science"},{"key":"9445_CR75","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1742-2094-9-8","volume":"9","author":"AM Martin-Moreno","year":"2012","unstructured":"Martin-Moreno AM, Brera B, Spuch C, Carro E, Garcia-Garcia L, Delgado M, Pozo MA, Innamorato NG, Cuadrado A, Ceballos ML (2012) Prolonged oral cannabinoid administration prevents neuroinflammation, lowers beta-amyloid levels and improves cognitive performance in Tg APP 2576 mice. J Neuroinflammation 9:8","journal-title":"J Neuroinflammation"},{"key":"9445_CR76","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/346561a0","volume":"346","author":"LA Matsuda","year":"1990","unstructured":"Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346:561\u2013564","journal-title":"Nature"},{"key":"9445_CR77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02190083","volume":"240","author":"M Maurer","year":"1990","unstructured":"Maurer M, Henn V, Dittrich A, Hofmann A (1990) Delta-9-tetrahydrocannabinol shows antispastic and analgesic effects in a single case double-blind trial. Eur Arch Psychiatry Clin Neurosci 240:1\u20134","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"9445_CR78","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1124\/jpet.102.033506","volume":"302","author":"RJ McKallip","year":"2002","unstructured":"McKallip RJ, Lombard C, Martin BR, Nagarkatti M, Nagarkatti PS (2002a) Delta(9)-tetrahydrocannabinol-induced apoptosis in the thymus and spleen as a mechanism of immunosuppression in vitro and in vivo. J Pharmacol Exp Ther 302:451\u2013465","journal-title":"J Pharmacol Exp Ther"},{"key":"9445_CR79","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1182\/blood-2002-01-0098","volume":"100","author":"RJ McKallip","year":"2002","unstructured":"McKallip RJ, Lombard C, Fisher M, Martin BR, Ryu S, Grant S, Nagarkatti PS, Nagarkatti M (2002b) Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease. Blood 100:627\u2013634","journal-title":"Blood"},{"key":"9445_CR80","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/0040-4020(65)80064-3","volume":"21","author":"R Mechoulam","year":"1965","unstructured":"Mechoulam R, Gaoni Y (1965) Hashish. IV. The isolation and structure of cannabinolic cannabidiolic and cannabigerolic acids. Tetrahedron 21:1223\u20131229","journal-title":"Tetrahedron"},{"key":"9445_CR81","first-page":"175","volume":"25","author":"R Mechoulam","year":"1967","unstructured":"Mechoulam R, Gaoni Y (1967) Recent advances in the chemistry of hashish. Fortschr Chem Org Naturst 25:175\u2013213","journal-title":"Fortschr Chem Org Naturst"},{"key":"9445_CR82","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1002\/cbdv.200790147","volume":"4","author":"R Mechoulam","year":"2007","unstructured":"Mechoulam R, Peters M, Murillo-Rodriguez E, Hanus LO (2007) Cannabidiol\u2013recent advances. Chem Biodivers 4:1678\u20131692","journal-title":"Chem Biodivers"},{"key":"9445_CR83","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1111\/j.1476-5381.2011.01673.x","volume":"165","author":"S Merighi","year":"2011","unstructured":"Merighi S, Gessi S, Varani K, Simioni C, Fazzi D, Mirandola P, Borea PA (2011) Cannabinoid CB(2) receptors modulate ERK-1\/2 kinase signalling and NO release in microglial cells stimulated with bacterial lipopolysaccharide. Br J Pharmacol 165:1773\u20131788","journal-title":"Br J Pharmacol"},{"key":"9445_CR84","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.mcn.2008.10.015","volume":"40","author":"L Mestre","year":"2009","unstructured":"Mestre L, Docagne F, Correa F, Loria F, Hernangomez M, Borrell J, Guaza C (2009) A cannabinoid agonist interferes with the progression of a chronic model of multiple sclerosis by downregulating adhesion molecules. Mol Cell Neurosci 40:258\u2013266","journal-title":"Mol Cell Neurosci"},{"key":"9445_CR85","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/sj.bjp.0707523","volume":"153","author":"AM Miller","year":"2008","unstructured":"Miller AM, Stella N (2008) CB2 receptor-mediated migration of immune cells: it can go either way. Br J Pharmacol 153:299\u2013308","journal-title":"Br J Pharmacol"},{"key":"9445_CR86","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1007\/s11481-011-9301-8","volume":"6","author":"PE Molina","year":"2011","unstructured":"Molina PE, Amedee A, LeCapitaine NJ, Zabaleta J, Mohan M, Winsauer P, Vande Stouwe C (2011) Cannabinoid neuroimmune modulation of SIV disease. J Neuroimmune Pharmacol 6:516\u2013527","journal-title":"J Neuroimmune Pharmacol"},{"key":"9445_CR87","doi-asserted-by":"crossref","unstructured":"Molina PE, Winsauer P, Zhang P, Walker E, Birke L, Amedee A, Stouwe CV, Troxclair D, McGoey R, Varner K, Byerley L, Lamotte L (2010) Cannabinoid Administration Attenuates the Progression of Simian Immunodeficiency Virus. AIDS Res Hum Retroviruses","DOI":"10.1089\/aid.2010.0218"},{"key":"9445_CR88","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0014-5793(98)00851-5","volume":"433","author":"F Molina-Holgado","year":"1998","unstructured":"Molina-Holgado F, Molina-Holgado E, Guaza C (1998) The endogenous cannabinoid anandamide potentiates interleukin-6 production by astrocytes infected with Theiler\u2019s murine encephalomyelitis virus by a receptor-mediated pathway. FEBS Lett 433:139\u2013142","journal-title":"FEBS Lett"},{"key":"9445_CR89","doi-asserted-by":"crossref","first-page":"H1145","DOI":"10.1152\/ajpheart.01328.2007","volume":"294","author":"F Montecucco","year":"2008","unstructured":"Montecucco F, Burger F, Mach F, Steffens S (2008) CB2 cannabinoid receptor agonist JWH-015 modulates human monocyte migration through defined intracellular signaling pathways. Am J Physiol Heart Circ Physiol 294:H1145\u2013H1155","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"9445_CR90","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/365061a0","volume":"365","author":"S Munro","year":"1993","unstructured":"Munro S, Thomas KL, Abu-Shaar M (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature 365:61\u201365","journal-title":"Nature"},{"key":"9445_CR91","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1096\/fj.09-141275","volume":"24","author":"S Murikinati","year":"2010","unstructured":"Murikinati S, Juttler E, Keinert T, Ridder DA, Muhammad S, Waibler Z, Ledent C, Zimmer A, Kalinke U, Schwaninger M (2010) Activation of cannabinoid 2 receptors protects against cerebral ischemia by inhibiting neutrophil recruitment. FASEB J 24:788\u2013798","journal-title":"FASEB J"},{"key":"9445_CR92","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/syn.20050","volume":"53","author":"E Nunez","year":"2004","unstructured":"Nunez E, Benito C, Pazos MR, Barbachano A, Fajardo O, Gonzalez S, Tolon RM, Romero J (2004) Cannabinoid CB2 receptors are expressed by perivascular microglial cells in the human brain: an immunohistochemical study. Synapse 53:208\u2013213","journal-title":"Synapse"},{"key":"9445_CR93","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1124\/mol.63.3.699","volume":"63","author":"L Offertaler","year":"2003","unstructured":"Offertaler L, Mo FM, Batkai S, Liu J, Begg M, Razdan RK, Martin BR, Bukoski RD, Kunos G (2003) Selective ligands and cellular effectors of a G protein-coupled endothelial cannabinoid receptor. Mol Pharmacol 63:699\u2013705","journal-title":"Mol Pharmacol"},{"key":"9445_CR94","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1124\/pr.58.3.2","volume":"58","author":"P Pacher","year":"2006","unstructured":"Pacher P, Batkai S, Kunos G (2006) The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev 58:389\u2013462","journal-title":"Pharmacol Rev"},{"key":"9445_CR95","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1126\/science.289.5480.739","volume":"289","author":"K Palczewski","year":"2000","unstructured":"Palczewski K, Kumasaka T, Hori T, Behnke CA, Motoshima H, Fox BA, Le Trong I, Teller DC, Okada T, Stenkamp RE, Yamamoto M, Miyano M (2000) Crystal structure of rhodopsin: A G protein-coupled receptor. Science 289:739\u2013745","journal-title":"Science"},{"key":"9445_CR96","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.nbd.2005.11.004","volume":"22","author":"D Panikashvili","year":"2006","unstructured":"Panikashvili D, Shein NA, Mechoulam R, Trembovler V, Kohen R, Alexandrovich A, Shohami E (2006) The endocannabinoid 2-AG protects the blood\u2013brain barrier after closed head injury and inhibits mRNA expression of proinflammatory cytokines. Neurobiol Dis 22:257\u2013264","journal-title":"Neurobiol Dis"},{"issue":"Suppl 1","key":"9445_CR97","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1016\/j.bbi.2011.03.001","volume":"25","author":"Y Persidsky","year":"2011","unstructured":"Persidsky Y, Ho W, Ramirez SH, Potula R, Abood ME, Unterwald E, Tuma R (2011) HIV-1 infection and alcohol abuse: neurocognitive impairment, mechanisms of neurodegeneration and therapeutic interventions. Brain Behav Immun 25(Suppl 1):S61\u2013S70","journal-title":"Brain Behav Immun"},{"key":"9445_CR98","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jneuroim.2003.10.026","volume":"147","author":"PK Peterson","year":"2004","unstructured":"Peterson PK, Gekker G, Hu S, Cabral G, Lokensgard JR (2004) Cannabinoids and morphine differentially affect HIV-1 expression in CD4(+) lymphocyte and microglial cell cultures. J Neuroimmunol 147:123\u2013126","journal-title":"J Neuroimmunol"},{"key":"9445_CR99","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1001\/jama.295.7.761","volume":"295","author":"FX Pi-Sunyer","year":"2006","unstructured":"Pi-Sunyer FX, Aronne LJ, Heshmati HM, Devin J, Rosenstock J (2006) Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial. JAMA 295:761\u2013775","journal-title":"JAMA"},{"key":"9445_CR100","doi-asserted-by":"crossref","first-page":"984","DOI":"10.2174\/138945012800675786","volume":"13","author":"A Pini","year":"2012","unstructured":"Pini A, Mannaioni G, Pellegrini-Giampietro D, Passani MB, Mastroianni R, Bani D, Masini E (2012) The role of cannabinoids in inflammatory modulation of allergic respiratory disorders, inflammatory pain and ischemic stroke. Curr Drug Targets 13:984\u2013993","journal-title":"Curr Drug Targets"},{"key":"9445_CR101","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.tins.2005.03.006","volume":"28","author":"G Pryce","year":"2005","unstructured":"Pryce G, Baker D (2005) Emerging properties of cannabinoid medicines in management of multiple sclerosis. Trends Neurosci 28:272\u2013276","journal-title":"Trends Neurosci"},{"key":"9445_CR102","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/(SICI)1098-1136(20000101)29:1<58::AID-GLIA6>3.0.CO;2-W","volume":"29","author":"RA Puffenbarger","year":"2000","unstructured":"Puffenbarger RA, Boothe AC, Cabral GA (2000) Cannabinoids inhibit LPS-inducible cytokine mRNA expression in rat microglial cells. Glia 29:58\u201369","journal-title":"Glia"},{"key":"9445_CR103","doi-asserted-by":"crossref","first-page":"12136","DOI":"10.1523\/JNEUROSCI.3402-08.2008","volume":"28","author":"I Racz","year":"2008","unstructured":"Racz I, Nadal X, Alferink J, Banos JE, Rehnelt J, Martin M, Pintado B, Gutierrez-Adan A, Sanguino E, Bellora N, Manzanares J, Zimmer A, Maldonado R (2008) Interferon-gamma is a critical modulator of CB(2) cannabinoid receptor signaling during neuropathic pain. J Neurosci 28:12136\u201312145","journal-title":"J Neurosci"},{"key":"9445_CR104","doi-asserted-by":"crossref","first-page":"H2210","DOI":"10.1152\/ajpheart.00688.2007","volume":"293","author":"M Rajesh","year":"2007","unstructured":"Rajesh M, Mukhopadhyay P, Batkai S, Hasko G, Liaudet L, Huffman JW, Csiszar A, Ungvari Z, Mackie K, Chatterjee S, Pacher P (2007) CB2-receptor stimulation attenuates TNF-alpha-induced human endothelial cell activation, transendothelial migration of monocytes, and monocyte-endothelial adhesion. Am J Physiol Heart Circ Physiol 293:H2210\u2013H2218","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"9445_CR105","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1523\/JNEUROSCI.4540-04.2005","volume":"25","author":"BG Ramirez","year":"2005","unstructured":"Ramirez BG, Blazquez C, Gomez del Pulgar T, Guzman M, de Ceballos ML (2005) Prevention of Alzheimer\u2019s disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation. J Neurosci 25:1904\u20131913","journal-title":"J Neurosci"},{"key":"9445_CR106","doi-asserted-by":"crossref","first-page":"4004","DOI":"10.1523\/JNEUROSCI.4628-11.2012","volume":"32","author":"SH Ramirez","year":"2012","unstructured":"Ramirez SH, Hasko J, Skuba A, Fan S, Dykstra H, McCormick R, Reichenbach N, Krizbai I, Mahadevan A, Zhang M, Tuma R, Son YJ, Persidsky Y (2012) Activation of cannabinoid receptor 2 attenuates leukocyte-endothelial cell interactions and blood\u2013brain barrier dysfunction under inflammatory conditions. J Neurosci 32:4004\u20134016","journal-title":"J Neurosci"},{"key":"9445_CR107","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.imbio.2009.04.001","volume":"215","author":"SA Rieder","year":"2010","unstructured":"Rieder SA, Chauhan A, Singh U, Nagarkatti M, Nagarkatti P (2010) Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression. Immunobiology 215:598\u2013605","journal-title":"Immunobiology"},{"key":"9445_CR108","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000097072","volume":"79","author":"AM Ronco","year":"2007","unstructured":"Ronco AM, Llanos M, Tamayo D, Hirsch S (2007) Anandamide inhibits endothelin-1 production by human cultured endothelial cells: a new vascular action of this endocannabinoid. Pharmacology 79:12\u201316","journal-title":"Pharmacology"},{"key":"9445_CR109","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1002\/cbdv.200790150","volume":"4","author":"EB Russo","year":"2007","unstructured":"Russo EB, Guy GW, Robson PJ (2007) Cannabis, pain, and sleep: lessons from therapeutic clinical trials of Sativex, a cannabis-based medicine. Chem Biodivers 4:1729\u20131743","journal-title":"Chem Biodivers"},{"key":"9445_CR110","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.febslet.2004.11.085","volume":"579","author":"E Ryberg","year":"2005","unstructured":"Ryberg E, Vu HK, Larsson N, Groblewski T, Hjorth S, Elebring T, Sjogren S, Greasley PJ (2005) Identification and characterisation of a novel splice variant of the human CB1 receptor. FEBS Lett 579:259\u2013264","journal-title":"FEBS Lett"},{"key":"9445_CR111","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.clim.2011.02.010","volume":"142","author":"AJ Sanchez","year":"2011","unstructured":"Sanchez AJ, Garcia-Merino A (2011) Neuroprotective agents: cannabinoids. Clin Immunol 142:57\u201367","journal-title":"Clin Immunol"},{"key":"9445_CR112","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1158\/0008-5472.CAN-07-2785","volume":"68","author":"S Sarfaraz","year":"2008","unstructured":"Sarfaraz S, Adhami VM, Syed DN, Afaq F, Mukhtar H (2008) Cannabinoids for cancer treatment: progress and promise. Cancer Res 68:339\u2013342","journal-title":"Cancer Res"},{"key":"9445_CR113","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1586\/ern.11.47","volume":"11","author":"J Sastre-Garriga","year":"2007","unstructured":"Sastre-Garriga J, Vila C, Clissold S, Montalban X (2007) THC and CBD oromucosal spray (Sativex(R)) in the management of spasticity associated with multiple sclerosis. Expert Rev Neurother 11:627\u2013637","journal-title":"Expert Rev Neurother"},{"key":"9445_CR114","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0165-5728(94)90152-X","volume":"55","author":"H Schwarz","year":"1994","unstructured":"Schwarz H, Blanco FJ, Lotz M (1994) Anadamide, an endogenous cannabinoid receptor agonist inhibits lymphocyte proliferation and induces apoptosis. J Neuroimmunol 55:107\u2013115","journal-title":"J Neuroimmunol"},{"key":"9445_CR115","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1124\/jpet.105.089474","volume":"315","author":"JL Shoemaker","year":"2005","unstructured":"Shoemaker JL, Ruckle MB, Mayeux PR, Prather PL (2005) Agonist-directed trafficking of response by endocannabinoids acting at CB2 receptors. J Pharmacol Exp Ther 315:828\u2013838","journal-title":"J Pharmacol Exp Ther"},{"key":"9445_CR116","doi-asserted-by":"crossref","unstructured":"Solas M, Francis PT, Franco R, Ramirez MJ (2012) CB(2) receptor and amyloid pathology in frontal cortex of Alzheimer\u2019s disease patients. Neurobiol Aging","DOI":"10.1016\/j.neurobiolaging.2012.06.005"},{"key":"9445_CR117","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1002\/ibd.20960","volume":"15","author":"MA Storr","year":"2009","unstructured":"Storr MA, Keenan CM, Zhang H, Patel KD, Makriyannis A, Sharkey KA (2009) Activation of the cannabinoid 2 receptor (CB2) protects against experimental colitis. Inflamm Bowel Dis 15:1678\u20131685","journal-title":"Inflamm Bowel Dis"},{"key":"9445_CR118","first-page":"605","volume":"55","author":"Q Tao","year":"1999","unstructured":"Tao Q, McAllister SD, Andreassi J, Nowell KW, Cabral GA, Hurst DP, Bachtel K, Ekman MC, Reggio PH, Abood ME (1999) Role of a conserved lysine residue in the peripheral cannabinoid receptor (CB2): evidence for subtype specificity. Mol Pharmacol 55:605\u2013613","journal-title":"Mol Pharmacol"},{"key":"9445_CR119","doi-asserted-by":"crossref","first-page":"487","DOI":"10.6004\/jnccn.2012.0048","volume":"10","author":"B Todaro","year":"2012","unstructured":"Todaro B (2012) Cannabinoids in the treatment of chemotherapy-induced nausea and vomiting. J Natl Compr Canc Netw 10:487\u2013492","journal-title":"J Natl Compr Canc Netw"},{"key":"9445_CR120","doi-asserted-by":"crossref","first-page":"499","DOI":"10.4049\/jimmunol.0900203","volume":"183","author":"J Tschop","year":"2009","unstructured":"Tschop J, Kasten KR, Nogueiras R, Goetzman HS, Cave CM, England LG, Dattilo J, Lentsch AB, Tschop MH, Caldwell CC (2009) The cannabinoid receptor 2 is critical for the host response to sepsis. J Immunol 183:499\u2013505","journal-title":"J Immunol"},{"key":"9445_CR121","doi-asserted-by":"crossref","first-page":"46","DOI":"10.2174\/138920112798868665","volume":"13","author":"RF Tuma","year":"2012","unstructured":"Tuma RF, Steffens S (2012) Targeting the endocannabinod system to limit myocardial and cerebral ischemic and reperfusion injury. Curr Pharm Biotechnol 13:46\u201358","journal-title":"Curr Pharm Biotechnol"},{"key":"9445_CR122","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/sj.bjp.0705100","volume":"138","author":"ET Tzavara","year":"2003","unstructured":"Tzavara ET, Davis RJ, Perry KW, Li X, Salhoff C, Bymaster FP, Witkin JM, Nomikos GG (2003) The CB1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: implications for therapeutic actions. Br J Pharmacol 138:544\u2013553","journal-title":"Br J Pharmacol"},{"key":"9445_CR123","doi-asserted-by":"crossref","first-page":"4564","DOI":"10.1523\/JNEUROSCI.0786-09.2009","volume":"29","author":"MT Viscomi","year":"2009","unstructured":"Viscomi MT, Oddi S, Latini L, Pasquariello N, Florenzano F, Bernardi G, Molinari M, Maccarrone M (2009) Selective CB2 receptor agonism protects central neurons from remote axotomy-induced apoptosis through the PI3K\/Akt pathway. J Neurosci 29:4564\u20134570","journal-title":"J Neurosci"},{"key":"9445_CR124","first-page":"995","volume":"285","author":"JL Wiley","year":"1998","unstructured":"Wiley JL, Compton DR, Dai D, Lainton JA, Phillips M, Huffman JW, Martin BR (1998) Structure-activity relationships of indole- and pyrrole-derived cannabinoids. J Pharmacol Exp Ther 285:995\u20131004","journal-title":"J Pharmacol Exp Ther"},{"key":"9445_CR125","unstructured":"Williams PB, Martin BR, Lattanzio FA, Samudre S, Razdan RK (2007) Novel cannabinoids and methods of use. In"},{"key":"9445_CR126","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.tips.2005.10.006","volume":"26","author":"JM Witkin","year":"2005","unstructured":"Witkin JM, Tzavara ET, Davis RJ, Li X, Nomikos GG (2005) A therapeutic role for cannabinoid CB1 receptor antagonists in major depressive disorders. Trends Pharmacol Sci 26:609\u2013617","journal-title":"Trends Pharmacol Sci"},{"key":"9445_CR127","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2174\/156802608783498023","volume":"8","author":"K Woelkart","year":"2008","unstructured":"Woelkart K, Salo-Ahen OM, Bauer R (2008) CB receptor ligands from plants. Curr Top Med Chem 8:173\u2013186","journal-title":"Curr Top Med Chem"},{"key":"9445_CR128","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.brainres.2008.08.027","volume":"1238","author":"JC Xiao","year":"2008","unstructured":"Xiao JC, Jewell JP, Lin LS, Hagmann WK, Fong TM, Shen CP (2008) Similar in vitro pharmacology of human cannabinoid CB1 receptor variants expressed in CHO cells. Brain Res 1238:36\u201343","journal-title":"Brain Res"},{"key":"9445_CR129","doi-asserted-by":"crossref","first-page":"3605","DOI":"10.1074\/jbc.M410294200","volume":"280","author":"XQ Xie","year":"2005","unstructured":"Xie XQ, Chen JZ (2005) NMR structural comparison of the cytoplasmic juxtamembrane domains of G-protein-coupled CB1 and CB2 receptors in membrane mimetic dodecylphosphocholine micelles. J Biol Chem 280:3605\u20133612","journal-title":"J Biol Chem"},{"key":"9445_CR130","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/prot.10511","volume":"53","author":"XQ Xie","year":"2003","unstructured":"Xie XQ, Chen JZ, Billings EM (2003) 3D structural model of the G-protein-coupled cannabinoid CB2 receptor. Proteins 53:307\u2013319","journal-title":"Proteins"},{"key":"9445_CR131","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/978-3-540-88955-7_2","volume":"1","author":"B Yao","year":"2009","unstructured":"Yao B, Mackie K (2009) Endocannabinoid receptor pharmacology. Curr Top Behav Neurosci 1:37\u201363","journal-title":"Curr Top Behav Neurosci"},{"key":"9445_CR132","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.preteyeres.2008.07.002","volume":"27","author":"S Yazulla","year":"2008","unstructured":"Yazulla S (2008) Endocannabinoids in the retina: from marijuana to neuroprotection. Prog Retin Eye Res 27:501\u2013526","journal-title":"Prog Retin Eye Res"},{"key":"9445_CR133","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1471-2377-6-12","volume":"6","author":"Y Yiangou","year":"2006","unstructured":"Yiangou Y, Facer P, Durrenberger P, Chessell IP, Naylor A, Bountra C, Banati RR, Anand P (2006) COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells\/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord. BMC Neurol 6:12","journal-title":"BMC Neurol"},{"key":"9445_CR134","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.pain.2010.07.019","volume":"151","author":"XH Yu","year":"2010","unstructured":"Yu XH, Cao CQ, Martino G, Puma C, Morinville A, St-Onge S, Lessard E, Perkins MN, Laird JM (2010) A peripherally restricted cannabinoid receptor agonist produces robust anti-nociceptive effects in rodent models of inflammatory and neuropathic pain. Pain 151:337\u2013344","journal-title":"Pain"},{"key":"9445_CR135","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1038\/sj.jcbfm.9600447","volume":"27","author":"M Zhang","year":"2007","unstructured":"Zhang M, Martin BR, Adler MW, Razdan RK, Jallo JI, Tuma RF (2007) Cannabinoid CB(2) receptor activation decreases cerebral infarction in a mouse focal ischemia\/reperfusion model. J Cereb Blood Flow Metab 27:1387\u20131396","journal-title":"J Cereb Blood Flow Metab"},{"key":"9445_CR136","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.mvr.2009.03.005","volume":"78","author":"M Zhang","year":"2009","unstructured":"Zhang M, Adler MW, Abood ME, Ganea D, Jallo J, Tuma RF (2009) CB2 receptor activation attenuates microcirculatory dysfunction during cerebral ischemic\/reperfusion injury. Microvasc Res 78:86\u201394","journal-title":"Microvasc Res"},{"key":"9445_CR137","first-page":"1103","volume":"286","author":"W Zhu","year":"1998","unstructured":"Zhu W, Friedman H, Klein TW (1998) Delta9-tetrahydrocannabinol induces apoptosis in macrophages and lymphocytes: involvement of Bcl-2 and caspase-1. J Pharmacol Exp Ther 286:1103\u20131109","journal-title":"J Pharmacol Exp Ther"},{"key":"9445_CR138","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1007\/s00251-006-0138-x","volume":"58","author":"D Ziring","year":"2006","unstructured":"Ziring D, Wei B, Velazquez P, Schrage M, Buckley NE, Braun J (2006) Formation of B and T cell subsets require the cannabinoid receptor CB2. Immunogenetics 58:714\u2013725","journal-title":"Immunogenetics"},{"key":"9445_CR139","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1590\/S0100-879X2006000400001","volume":"39","author":"AW Zuardi","year":"2006","unstructured":"Zuardi AW, Crippa JA, Hallak JE, Moreira FA, Guimaraes FS (2006a) Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug. Braz J Med Biol Res 39:421\u2013429","journal-title":"Braz J Med Biol Res"},{"key":"9445_CR140","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1177\/0269881106060967","volume":"20","author":"AW Zuardi","year":"2006","unstructured":"Zuardi AW, Hallak JE, Dursun SM, Morais SL, Sanches RF, Musty RE, Crippa JA (2006b) Cannabidiol monotherapy for treatment-resistant schizophrenia. J Psychopharmacol 20:683\u2013686","journal-title":"J Psychopharmacol"}],"container-title":["Journal of Neuroimmune Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-013-9445-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11481-013-9445-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-013-9445-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,10]],"date-time":"2019-07-10T15:32:56Z","timestamp":1562772776000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11481-013-9445-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,8]]},"references-count":140,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["9445"],"URL":"https:\/\/doi.org\/10.1007\/s11481-013-9445-9","relation":{},"ISSN":["1557-1890","1557-1904"],"issn-type":[{"value":"1557-1890","type":"print"},{"value":"1557-1904","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,8]]}}}